Actively Recruiting
Study of Rituximab Combined With AB-101 to Treat Adults With B-cell Autoimmune Diseases Including Rheumatoid Arthritis, Pemphigus Vulgaris, Granulomatosis With Polyangiitis, and Systemic Lupus Erythematosus
Led by IRIS Research and Development, LLC · Updated on 2024-09-03
30
Participants Needed
1
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and activity of AB-101 combined with rituximab in adults with B-cell associated autoimmune diseases where rituximab is approved or recommended. These diseases include Rheumatoid Arthritis, Pemphigus Vulgaris, Granulomatosis with polyangiitis or microscopic polyangiitis, and Systemic Lupus Erythematosus. The study is a Phase 1, open-label trial conducted by IRIS Research and Development, LLC to explore this combination treatment. Participants will receive one cycle of treatment tailored to their specific condition. For Rheumatoid Arthritis, Pemphigus Vulgaris, or Systemic Lupus Erythematosus, treatment includes fludarabine on Days 1-3, cyclophosphamide on Day 3, rituximab on Days 1 and 15, and AB-101 NK cells on Days 6, 13, and 20. For Granulomatosis with polyangiitis or microscopic polyangiitis, rituximab is given on Days -2, 6, 13, and 20 with the other drugs on the same schedule. AB-101 is administered at least 48 hours after the last lymphodepletion infusion. Participants will be monitored for adverse events, serious adverse events, and hospitalizations from consent through 104 weeks after treatment starts. Disease activity scores specific to each condition will be evaluated at Weeks 12 and 24 to assess changes. Safety and efficacy assessments include laboratory tests, clinical evaluations, and disease activity indices. The total participation may extend over two years to capture long-term safety and treatment effects.
CONDITIONS
Brief Title
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Research Team
K
Kathy I Perez, M.D.
J
Jhon Galindo, B.S.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here